EIR Karyopharm Therapeutics Feb 2020

Min Lu FDA, Matthew Watson FDA, Ling Yang FDA$595.00 - Available Now

FDA investigators audited the Karyopharm Therapeutics - Newton, MA, United States facility and issued inspectional observation (via FDA 483) on 28 Feb 2020.

Product details

  • Category:
  • Inspection end: 28 Feb 2020
  • Location: Newton, United States
  • FEI: 3012640137
Add To Cart